Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Cancer. 2023 Jun 1;129(17):2741–2753. doi: 10.1002/cncr.34818

Figure 4. Associations between adjusted Extrinsic Epigenetic Age (EEA) and self-reported cognition among older breast cancer survivors by systemic therapy modality and non-cancer controls at the first blood sample, approximately 24- to 36-months after enrollment.

Figure 4.

Multiple regression models showing the association between adjusted EEA clock scores and self-reported cognition (FACT-Cog PCI scores) for survivors who received chemotherapy with or without hormonal therapy (n=29) and those who received hormonal therapy alone (n=51) relative to controls (n=101,). Models adjusted for chronological age at the first blood sample, comorbidities, racial group, site, and cognitive reserve (WRAT-4 score). Error bars represent 95% confidence intervals for each point estimate.